http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6330058-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c6a921f33fe0adc58c2b6177184515
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-31
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-80
filingDate 2000-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f47be9c963dd463a172c7f0ce71c5a60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ffbba21b79ac6d20a099030a66f52ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd232d66118a9bacebc4b7123985a826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f03b39999878bd1cfdc1de8457342d78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7f83a5a9d88335b717281b9e399b50f
publicationDate 2001-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6330058-B1
titleOfInvention Spectrophotometric method and apparatus for blood typing
abstract A method and apparatus for characterizing the type of a blood sample are provided wherein an optical density spectrum of the sample is collected over a predetermined wavelength range. A reference optical density spectrum is collected over a predetermined wavelength range for a portion of the blood sample diluted in saline. Another portion of the blood sample is then mixed with an antibody corresponding to a known blood type (e.g., anti-A, anti-B, anti-D antibody). The optical density spectrum is then collected over a predetermined wavelength range for blood diluted with saline and each antibody in saline. The slopes are then calculated over a predetermined wavelength range for each spectrum. A numerical indicator of agglutination is then calculated by dividing the slope of each antibody-treated sample by the slope of the sample in saline. The resulting number is multiplied by 100. The agglutination index (AI) is arrived at by subtracting this number from 100 so that the magnitude of the AI is a reflection of the degree of agglutination of the sample. A high index value indicates large agglutination (i.e., strong interaction with antibody). Blood type is determined by comparing the AI to a predetermined empirical cutoff value. Typically cutoff values greater than 17 indicate type-specific interaction (type AB samples yield AI values over 17 with both anti-A and anti-B antibodies, while type O samples yield AI values less than 17 with both anti-A and anti-B antibodies).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022066126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007035820-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010159500-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7096124-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8450082-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006114553-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6992819-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005168810-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7495827-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003178569-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7397601-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7978405-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7700360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7560277-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2056091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004065951-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005233439-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014167496-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004008522-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6865013-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7009180-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1738155-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11288794-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005001446-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7106503-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007042346-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005197790-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109932517-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8675185-B2
priorityDate 1999-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4988630-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5110726-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5261410-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5180661-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4213764-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5377674-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5674699-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4655225-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5325295-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4805623-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5336597-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4281645-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5259382-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5197470-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4223680-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4851210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4446239-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4713348-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7187
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4298
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4298

Total number of triples: 71.